PMID- 35637975 OWN - NLM STAT- MEDLINE DCOM- 20220602 LR - 20220716 IS - 1942-0994 (Electronic) IS - 1942-0900 (Print) IS - 1942-0994 (Linking) VI - 2022 DP - 2022 TI - TREM-1 Modulates Dendritic Cells Maturation and Dendritic Cell-Mediated T-Cell Activation Induced by ox-LDL. PG - 3951686 LID - 10.1155/2022/3951686 [doi] LID - 3951686 AB - Atherosclerosis is a chronic inflammatory disease. The triggering receptor expressed on myeloid cells-1 (TREM-1) plays a crucial role in inflammatory diseases; recently, it was identified as a major upstream proatherogenic receptor, but its mechanism is still unclear. In this study, we explore the role of TREM-1 on dendritic cells maturation and inflammatory responses induced by ox-LDL and its possible mechanism. Human dendritic cells were differentiated from blood monocytes and treated with ox-LDL. Naive autologous T cells were cocultured with pretreated DCs or treated directly. The expression of TREM-1 and inflammatory factors were evaluated by real-time PCR, western blot, and ELISA methods. And the expression of immune factors to evaluate the DCs maturation and T-cell activation were determined by the FACS. Our study showed that ox-LDL induced TREM-1 expression, DC maturation, and T-cell activation. T cells exposed to ox-LDL-treated DCs produced interferon-gamma and interleukin-17 (IL-17). Blocking TREM-1 suppressed the DC maturation, showing lower expression of CD1a, CD40, CD86, CD83, and HLA-DR, and limited their production of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, IL-6, and monocyte chemoattractant protein-1 (MCP-1), meanwhile increased transforming growth factor-beta(TGF-beta) and IL-10 production. Ox-LDL induced miR-155, miR-27, Let-7c, and miR-185 expression; however, TREM-1 inhibiting decreased miRNA-155 expression. Furthermore, silencing miRNA-155 restores SOCS1 repression induced by ox-LDL. Experiments with T cells derived from carotid atherosclerotic plaques or healthy individuals showed similar results. Our results uncover a new link between ox-LDL and TREM-1 and may provide insight into this interaction in the context of atherosclerosis. CI - Copyright (c) 2022 Yun Kai Wang et al. FAU - Wang, Yun Kai AU - Wang YK AUID- ORCID: 0000-0001-7219-5458 AD - Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. FAU - Wang, Jie AU - Wang J AD - Department of Cardiology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China. FAU - Hua, Feng AU - Hua F AD - Department of Respiratory Medicine, Affiliated Huzhou Hospital, Zhejiang University school of Medicine, Huzhou, Zhejiang Province, China. FAU - Shen, Yun Li AU - Shen YL AD - Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. FAU - Han, Lu AU - Han L AD - Qingdao University Medical College, Qingdao, China. FAU - You, Jie Yun AU - You JY AD - Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. FAU - Wei, Wei AU - Wei W AD - Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. FAU - Zhang, Chun Yu AU - Zhang CY AD - Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China. FAU - Liu, Xiang Dong AU - Liu XD AD - Department of Emergency, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. FAU - Zhang, Qi AU - Zhang Q AUID- ORCID: 0000-0002-8935-8396 AD - Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. LA - eng PT - Journal Article DEP - 20220521 PL - United States TA - Oxid Med Cell Longev JT - Oxidative medicine and cellular longevity JID - 101479826 RN - 0 (Lipoproteins, LDL) RN - 0 (MIRN155 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (TREM1 protein, human) RN - 0 (Triggering Receptor Expressed on Myeloid Cells-1) RN - 0 (oxidized low density lipoprotein) SB - IM MH - *Atherosclerosis/metabolism MH - Dendritic Cells MH - Humans MH - Lipoproteins, LDL MH - MicroRNAs/metabolism MH - *Triggering Receptor Expressed on Myeloid Cells-1/metabolism PMC - PMC9148251 COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/06/01 06:00 MHDA- 2022/06/03 06:00 PMCR- 2022/05/21 CRDT- 2022/05/31 14:25 PHST- 2021/07/26 00:00 [received] PHST- 2022/03/21 00:00 [revised] PHST- 2022/04/05 00:00 [accepted] PHST- 2022/05/31 14:25 [entrez] PHST- 2022/06/01 06:00 [pubmed] PHST- 2022/06/03 06:00 [medline] PHST- 2022/05/21 00:00 [pmc-release] AID - 10.1155/2022/3951686 [doi] PST - epublish SO - Oxid Med Cell Longev. 2022 May 21;2022:3951686. doi: 10.1155/2022/3951686. eCollection 2022.